Sesen Bio Inc. [NASDAQ: SESN] traded at a low on 05/10/21, posting a -10.49 loss after which it closed the day’ session at $2.39. The company report on May 10, 2021 that Sesen Bio Reports First Quarter 2021 Financial Results and Commercial Launch Readiness Update in the US for Vicineum™.
Strengthened balance sheet with $110M in cash and cash equivalents as of March 31, 2021.
Company remains on track for potential approval in the US in August 2021 and in Europe in early 2022.
The results of the trading session contributed to over 12613463 shares changing hands. Over the past one week, the price volatility of Sesen Bio Inc. stands at 10.89% while the volatility over the past one month is 9.71%.
The market cap for SESN stock reached $397.27 million, with 132.57 million shares outstanding and 129.27 million shares in the current float. Compared to the average trading volume of 6.92M shares, SESN reached a trading volume of 12613463 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Sesen Bio Inc. [SESN]?
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 11, 2019.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.23, with the Price to Sales ratio for SESN stock in the period of the last 12 months amounting to 35.47.
How has SESN stock performed recently?
Sesen Bio Inc. [SESN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.34. With this latest performance, SESN shares dropped by -5.16% in over the last four-week period, additionally plugging by 125.47% over the last 6 months – not to mention a rise of 196.01% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 40.61, with the RSI for the last a single of trading hit 34.97, and the three-weeks RSI is set at 44.05 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 2.67, while it was recorded at 2.67 for the last single week of trading, and 1.74 for the last 200 days.
Sesen Bio Inc. [SESN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Sesen Bio Inc. [SESN] shares currently have an operating margin of -287.09. Sesen Bio Inc.’s Net Margin is presently recorded at -199.33.
Reflecting on the efficiency of the workforce at the company, Sesen Bio Inc. [SESN] managed to generate an average of -$829,519 per employee.Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.50 and a Current Ratio set at 3.50.
Earnings analysis for Sesen Bio Inc. [SESN]
With the latest financial reports released by the company, Sesen Bio Inc. posted 0.31/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 444.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SESN.
Insider trade positions for Sesen Bio Inc. [SESN]
There are presently around $77 million, or 17.00% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: VANGUARD GROUP INC with ownership of 5,893,620, which is approximately 25.393% of the company’s market cap and around 0.02% of the total institutional ownership; TRV GP, LLC, holding 4,841,591 shares of the stock with an approximate value of $12.93 million in SESN stocks shares; and BLACKROCK INC., currently with $7.8 million in SESN stock with ownership of nearly 53.421% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 33 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 6,448,727 shares. Additionally, 17 investors decreased positions by around 1,096,693 shares, while 12 investors held positions by with 21,138,181 shares. The mentioned changes placed institutional holdings at 28,683,601 shares, according to the latest SEC report filing. SESN stock had 15 new institutional investments in for a total of 1,506,374 shares, while 2 institutional investors sold positions of 215,818 shares during the same period.